This white paper shows, at-a-glance, the new features and improvements in the latest version of this CDISC standard and its day-to-day use.
Formedix CEO Mark Wheeldon's presentation from the 2013 Bay Area User Group, which looks at practical uses of Define-XML in the end-to-end clinical trial process.
Presentation by David Borbas, Jazz Pharmaceuticals discussing Define-XML at our executive breakfast as sponsors of the Bay Area User Group.
CDISC President Rebecca Kush presented at our executive breakfast prior to the Bay Area User Group, discussing CDISC's strategy from 2013 - 2015.
Presentation from Formedix-hosted Bay Area Executive Breakfast, discussing standards to enable efficiencies throughout the end-to-end clinical trial process.
This presentation from CDISC Europe Interchange 2013 explains how an ‘iTunes-style’ metadata repository can be established using CDISC standardized content, in a CDISC vendor-neutral model.
Presentation from the 2012 DIA Clinical Data Quality Summit, discussing end-to-end clinical trial automation and CDISC models being adopted from study setup to submission.
CEO Mark Wheeldon's presentation from DIA EuroMeeting, March 2012, on how CDISC models can be adopted throughout the end-to-end clinical trial process.
Formedix CEO Mark Wheeldon presented at ESUG Meeting, November 2012, discussing how the end-to-end clinical trial process can be made more efficient using CDISC standards.